Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis

Journal of Infection

Volumn 49, Issue 4, 2004, Pages 302-309

  Marrie, Thomas J ^a   Beecroft, Michael D ^b   Herman Gnjidic, Zeljka ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Bayer Inc   (Canada)

Author keywords

Chest pain; Cough; Dyspnoea; Fatigue; Pneumonia; Resolution; Severity; Sputum; Symptoms

Indexed keywords

CLARITHROMYCIN; MOXIFLOXACIN;

ADULT; AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DYSPNEA; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; THORAX PAIN; THORAX RADIOGRAPHY; TIME; TREATMENT OUTCOME; WORK RESUMPTION;

ADULT; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CLARITHROMYCIN; COMMUNITY-ACQUIRED INFECTIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; QUINOLINES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 5044245289     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2003.11.013     Document Type: Article

References (22)

1. Jokinen C. Heiskanen L. Juvonen H. et al. Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland Am J Epidemiol 137 1993 977-988
2. Mandell L.A. Marrie T.J. Grossman R.F. et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society Clin Infect Dis 31 2000 383-421
3. Bartlett J.G. Dowell S.F. Mandell L.A. et al. Practice guidelines for the management of community-acquired pneumonia in adults Clin Infect Dis 31 2000 347-382
4. Bartlett J.G. Mundy L.M. Community-acquired pneumonia N Engl J Med 333 1995 1618-1624
5. Fine M.J. Smith M.A. Carson C.A. et al. Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis JAMA 274 1995 134-141
6. Meehan T.P. Fine M.J. Krumholz H.M. et al. Quality of care, process, and outcomes in elderly patients with pneumonia JAMA 278 1997 2080-2084
7. Ramirez J.A. Ahkee S. Early switch from intravenous antimicrobials to oral clarithromycin in patients with community acquired pneumonia Infect Med 14 1997 319-323
8. Lister P.D. Saunders C.C. Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae JAC 47 2001 811-818
9. DeAbate C.A. Mathew C.P. Warner J.H. et al. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis Respir Med 94 2000 1029-1037
10. Fine M.J. Auble T.E. Yealy D.M. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia NEJM 336 1997 243-250
11. Agresti A. Categorical data analysis 1990 Wiley New York
12. Metlay J.P. Schulz R. Li Y.-H. et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia Arch Intern Med 157 1997 1453-1459
13. Metlay J.P. Atlas S.J. Borowsky L.H. Singer D.E. Time course of symptom resolution in patients with community-acquired pneumonia Respir Med 92 1998 1137-1142
14. Metlay J.P. Fine M.J. Schulz R. et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia J Gen Intern Med 12 1997 423-430
15. Coley C.M. Li Y.-H. Medsger A. et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia Arch Intern Med 156 1996 565-571
16. Fine M.J. Stone R.A. Singer D.E. et al. Processes and outcomes of care for patients with community-acquired pneumonia. Results from the pneumonia patient outcomes research team (PORT) cohort study Arch Intern Med 159 1999 970-980
17. Brandenburg J.A. Marrie T.J. Coley C.M. et al. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia J Gen Intern Med 15 2000 638-646
18. Lamping D.L. Schroter S. Marquis P. Marrel A. Dupont-Lomon I. Saguier P.P. The community-acquired pneumonia symptom questionnaire. A new patient based outcome measure to evaluate symptoms in community-acquired pneumonia Chest 122 2002 920-929
19. Finch R. Schürmann D. Collins O. et al. Randomized controlled trial of sequential intravenous (I.V.) and oral moxifloxacin compared with sequential I.V. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment Antimicrob Agents Chemother 46 2002 1746-1754
20. Miravitlles M, Vidal R, Lamarca R, et al. Influence of antibiotic treatment on duration of symptoms of acute exacerbations of COPD. Poster. Presented at ATS, 2002.
21. Wilson R, Jones P, Schaberg T, et al. A Clinical and Outcomes Assessment of the Management of Acute Exacerbations of Chronic Bronchitis (AECB): The MOSAIC Study. Poster presented at ERS, 2002.
22. Torres A. Muir J.-F. Corris P. et al. Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia Eur Respir J 21 2003 135-143